Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Mar 14, 2018)
  • 8-K (Jan 19, 2018)
  • 8-K (Jan 17, 2018)
  • 8-K (Dec 28, 2017)
  • 8-K (Dec 11, 2017)
  • 8-K (Dec 6, 2017)

 
Other

AstroNova, Inc. 8-K 2005

Documents found in this filing:

  1. 8-K
  2. 8-K
Form 8-K GT Appointment
                UNITED STATES SECURITIES AND EXCHANGE COMMISSION


                             WASHINGTON, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT

                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934


                                 DATE OF REPORT

                                  JUNE 28, 2005

                        (DATE OF EARLIEST EVENT REPORTED)
                                 (JUNE 24, 2005)




                                 ASTRO-MED, INC
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)


                         COMMISSION FILE NUMBER 0-13200



          RHODE ISLAND                           05-0318215
          (STATE OR OTHER JURISDICTION OF        (IRS EMPLOYER IDENTIFICATION
          INCORPORATION OR ORGANIZATION)         NUMBER)


                600 EAST GREENWICH AVENUE, WEST WARWICK, RI 02893
          (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, INCLUDING ZIP CODE)



                                 (401-828-4000)
              (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)











ITEM 4.01. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.

On June 24, 2005, following the approval of its Audit Committee, the Registrant engaged the services
of Grant Thornton LLP (GT) as its principal accountant to audit the Company's financial statements.
GT will audit the financial statements of Astro-Med, Inc. for
the fiscal year ending January 31, 2006.


During the two most recent fiscal years of the Company ended January 31, 2005 and
2004 or any subsequent interim period prior to GT's engagement, the Company did
not consult with GT regarding any of the matters or events set forth in Item
304 (a) (2) (i) and (ii) of Regulation S-K.


SIGNATURES


Pursuant to the  requirements of the Securities  Exchange Act of 1934, the Registrant has duly caused
this report to be signed on their behalf by the undersigned thereunto duly authorized.

DATE: June 28, 2005                                  ASTRO-MED, INC.



                                                              By: /s/ Joseph P. O'Connell
                                                                  ----------------------------------------
                                                              Vice President ,Treasurer and Chief
                                                              Financial Officer



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki